Skip to main content
RARE filings

Corporate insider profile

Corazon (Corsee) D. Sanders Filing Activity

Latest reported as Director of Ultragenyx Pharmaceutical Inc. (RARE).

Purchase filings
0
Reported companies
2
Net open-market value
-$115,733.00
Latest transaction
Jun 15, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Ultragenyx Pharmaceutical Inc. (RARE)DirectorSale2,000$25.05$50,100
May 22, 2026BeOne Medicines Ltd. (ONC)Corporate insiderSale212$309.59$65,633